LEADER 03984nam 22006612 450 001 9910450363603321 005 20151005020622.0 010 $a1-107-12888-9 010 $a1-280-16021-7 010 $a9786610160211 010 $a1-139-14637-8 010 $a0-511-11846-5 010 $a0-511-06678-3 010 $a0-511-06047-5 010 $a0-511-30712-8 010 $a0-511-54569-X 010 $a0-511-06891-3 035 $a(CKB)1000000000017977 035 $a(EBL)217663 035 $a(OCoLC)475923864 035 $a(SSID)ssj0000141670 035 $a(PQKBManifestationID)11147367 035 $a(PQKBTitleCode)TC0000141670 035 $a(PQKBWorkID)10090536 035 $a(PQKB)10454596 035 $a(UkCbUP)CR9780511545696 035 $a(MiAaPQ)EBC217663 035 $a(Au-PeEL)EBL217663 035 $a(CaPaEBR)ebr10069951 035 $a(CaONFJC)MIL16021 035 $a(EXLCZ)991000000000017977 100 $a20090507d2003|||| uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aDrugs for the treatment of respiratory diseases /$fedited by Domenico Spina [and others]$b[electronic resource] 210 1$aCambridge :$cCambridge University Press,$d2003. 215 $a1 online resource (xii, 599 pages) $cdigital, PDF file(s) 300 $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015). 311 $a0-521-77321-0 320 $aIncludes bibliographical references and index. 327 $aCover; Half-title; Title; Copyright; Contents; Contributors; Preface; 1 Pathology of asthma and COPD: inflammation and structure; 2 Glucocorticosteroids; 3 Beta2-adrenoceptor agonists; 4 Anticholinergic bronchodilators; 5 Antiallergic drugs; 6 Drugs affecting the synthesis and action of leukotrienes; 7 Theophylline and selective phosphodiesterase inhibitors in the treatment of respiratory disease; 8 Potential therapeutic effects of potassium channel openers in respiratory diseases; 9 Tachykinin and kinin antagonists; 10 Drugs affecting IgE (synthesis inhibitors and monoclonal antibodies) 327 $a11 Drugs targeting cell signalling12 Current approaches to the treatment of parenchymal lung diseases; 13 Drug treatments of the future in fibrotic lung disease; 14 Current and future management of pneumonia; 15 Current treatment of chronic bronchial suppuration; 16 Current and future treatment of cystic fibrosis; 17 Pathophysiology of pulmonary vascular disease; 18 Current treatment of pulmonary vascular diseases; 19 Future treatment of pulmonary vascular diseases; 20 Molecular pathology of lung cancer; 21 Small cell lung cancer; 22 Mechanisms of cough; 23 Current treatment of cough; Index 330 $aRespiratory diseases affect millions of people each year and represent a major health burden around the world. This timely reference surveys and evaluates the drug treatments available for the main categories of lung diseases including asthma, tuberculosis, chronic obstructive pulmonary disease, lung cancer, and respiratory infections. The recent re-emergence of tuberculosis and the increase in asthma in certain populations underlines the importance of finding effective new treatments for these diseases. This publication, a comprehensive reference, is one of the first to survey current and novel drug treatments for this group of diseases. It is certain to establish itself as an essential source of reference for respiratory physicians, clinicians and clinical pharmacologists. 606 $aLungs$xDiseases$xChemotherapy 606 $aRespiratory agents 615 0$aLungs$xDiseases$xChemotherapy. 615 0$aRespiratory agents. 676 $a616.2/4061 702 $aSpina$b Domenico 801 0$bUkCbUP 801 1$bUkCbUP 906 $aBOOK 912 $a9910450363603321 996 $aDrugs for the treatment of respiratory diseases$92463963 997 $aUNINA